6/9/2020 7:09:41 AM
Sutro Biopharma To Present New Preclinical Data On STRO-002 Antibody-Drug Conjugate At AACR On June 22
5/21/2020 7:20:02 AM
Sutro Biopharma Names Craig Berman VP Of Clinical Development; Promotes Regina Cheng To VP Of Finance And Controller
5/21/2020 7:12:18 AM
Sutro Biopharma Names Carlos Paya Chair Of Scientific Advisory Board And Lainie Martin Member Of Clinical Advisory Board
5/12/2020 12:00:34 AM
Sutro Biopharma Announces Pricing Of 11 Mln Shares At $7.75/Shr
5/11/2020 4:04:15 PM
Sutro Biopharma Announces Proposed Public Offering
4/27/2020 12:03:43 AM
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data For Dose Escalation Study Of STRO-002
3/16/2020 7:21:33 AM
Sutro Biopharma FY Net Loss Widens To $55.7 Mln From $35.3 Mln Last Year
3/12/2020 7:07:10 AM
Sutro Biopharma Extends First Cytokine Derivative Research Program Under Collaboration With Merck By One Year
1/8/2020 9:27:57 AM
Sutro Biopharma Adds James Panek To Board
11/8/2019 7:07:07 AM
Sutro Biopharma Q3 Loss Per Share $0.56 Vs Loss $21.26 Last Year
8/14/2019 6:24:42 AM
Sutro Biopharma Q2 Revenue $10.5 Mln Vs $5.7 Mln Last Year
6/24/2019 4:12:39 PM
Sutro Biopharma Appoints Connie Matsui As Board Chair
6/15/2019 6:05:48 AM
Sutro Biopharma Announces Encouraging Interim Phase 1 Safety Data Of STRO-001 For B-cell Malignancies
4/2/2019 7:11:26 AM
Wedbush Is Cutting SUTRO BIOPHARMA INC (STRO) Q4 19 Rev. Estimate To 11.3 M From 23.8 M
4/2/2019 7:11:13 AM
Wedbush Is Cutting SUTRO BIOPHARMA INC (STRO) Q3 19 Rev. Estimate To 11.3 M From 13.8 M